Literature DB >> 1652880

A multivariate study of simultaneous escape from suppression by dexamethasone of urinary free cortisol, plasma cortisol, adrenocorticotropic hormone and beta-endorphin in melancholic patients.

M Maes1, C Vandervorst, E Suy, B Minner, J Raus.   

Abstract

To investigate the relationships between pre- and postdexamethasone hypothalamic-pituitary-adrenal (HPA) axis functioning in depression, we measured the levels of baseline and postdexamethasone urinary free cortisol (UFC), plasma cortisol, adrenocorticotropic hormone (ACTH) and beta-endorphin. We found that dexamethasone significantly suppressed all hormone levels. All 4 postdexamethasone hormones--but not their baseline levels--were significantly higher in melancholic subjects than in minor and simple major depressives. We have accumulated evidence that the melancholic and minor depression groups form discrete classes in postdexamethasone HPA axis hormone levels; this supports the biological heterogeneity hypothesis of melancholia. We found that a combination of the postdexamethasone UFC and beta-endorphin values yielded the most significant diagnostic tool for melancholia. Our results suggest that the measurements of both hormones may constitute the most accurate index reflecting the HPA axis escape from suppression by dexamethasone in melancholia. By means of pathway analysis, we determined the causal relationships between age, dexamethasone circulating levels, diagnostic depression classification and the various baseline and postdexamethasone hormone values.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1652880     DOI: 10.1111/j.1600-0447.1991.tb05580.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  2 in total

1.  Immunoendocrine aspects of major depression. Relationships between plasma interleukin-6 and soluble interleukin-2 receptor, prolactin and cortisol.

Authors:  M Maes; E Bosmans; H Y Meltzer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1995       Impact factor: 5.270

2.  Beta-Endorphin and Oxytocin in Patients with Alcohol Use Disorder and Comorbid Depression.

Authors:  Olga V Roschina; Lyudmila A Levchuk; Anastasiia S Boiko; Ekaterina V Michalitskaya; Elena V Epimakhova; Innokentiy S Losenkov; German G Simutkin; Anton J M Loonen; Nikolay A Bokhan; Svetlana A Ivanova
Journal:  J Clin Med       Date:  2021-12-03       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.